This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Charcot-marie-tooth Disease
Information about Charcot-marie-tooth Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Charcot-marie-tooth Disease
Most recent studies have shown that Charcot-marie-tooth Disease shares some biological mechanisms with ataxia, atrophy, charcot-marie-tooth-disease-type-ia-(disorder), demyelinating-diseases, demyelination, hereditary-liability-to-pressure-palsies, hereditary-motor-and-sensory-neuropathies, hypertrophy, inherited-neuropathy, muscle-weakness, muscular-atrophy, muscular-dystrophy, nervousness, neuromuscular-diseases, peripheral-neuropathy, polyneuropathy, sensory-neuropathy, spinal-muscular-atrophy, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Charcot-marie-tooth Disease, and have been seen in publications frequently: Cell Death, Cell Growth, Cell Proliferation, Endocytosis, Glycosylation, Innervation, Interphase, Localization, Meiosis, Mitochondrial Fission, Mitochondrial Fusion, Muscle Atrophy, Myelin Maintenance, Myelination, Pathogenesis, Reflex, Regeneration, Schwann Cell Proliferation, Translation, Transport
Quite a number of genes have been found to play important roles in Charcot-marie-tooth Disease, such as DNM2, EGR2, GDAP1, GDI1, GJB1, HSPB1, KIF1B, LMNA, MAD2L1BP, MFN2, MPZ, MTMR2, NEFL, PES1, PMP22, PXMP2, RPLP0, SBF2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.